Wednesday, February 10, 2010, 12:25PM AEST - The Australian Stockmarket closes in 3 hours and 40 minutes.
To create a watchlist or portfolio of shares, Register

Clinical Data, Inc. (CLDA)

 8:00AM AEST: 15.37 USD  Up 0.58 (3.92%)  
 MORE ON CLDA 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Clinical Data, Inc. (NGM:CLDA) Delayed quote dataEdit
Last Trade:15.37 USD
Trade Time: 8:00AM AEST
Change:Up 0.58 (3.92%)
Prev Close:14.79
Open:14.97
Bid:14.82 x 200
Ask:15.92 x 200
1y Target Est:28.00
Day's Range:14.80 - 15.71
52wk Range:7.36 - 21.94
Volume:79,951
Avg Vol (3m):100,287
Market Cap:407.17M
P/E (ttm):N/A
EPS (ttm):-3.53
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add CLDA to Portfolio   Download Data

 HEADLINES 
•No Affymetrix Performance from Illumina; Stock Sinks as Year Forecast Misses
at Barrons.com (Wed 12:20PM)
•CLINICAL DATA INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Wed 8:31AM)
•Earnings roundup: Coca-Cola, Gartner
AP (Wed 6:18AM)
•Clinical Data 3Q loss narrows on sales boost
AP (Wed 3:29AM)
•InPlay: Clinical Data reports 3Q10 loss per share of ($0.63) vs. ($0.65) First Call consensus; revenue increased 12.5% y/y to $3.1 mln vs. $3.6 mln consensus
Briefing.com (Tue 11:22PM)
•Clinical Data, Inc. Reports Third Quarter Fiscal 2010 Results
Business Wire (Tue 11:20PM)
•Clinical Data, Inc. to Present at the BIO CEO & Investor Conference
Business Wire (Tue, Feb 2)
•[video] Trading Smallcap Biotech
at TheStreet.com (Tue, Feb 2)
•Loomis Sayles Fund Avoids Financials
at TheStreet.com (Fri, Jan 29)
•Clinical Data, Inc. to Present at J.P. Morgan Healthcare Conference
Business Wire (Wed, Jan 6)
•Clinical Data, Inc. Establishes Research Collaboration to Study Genetic Variants Associated with Response to Clopidogrel
Business Wire (Tue, Dec 22)
More Headlines for CLDA...
 ANALYST 
EPS Est (next year) (Mar-10) :-2.63
EPS Est (in 2 years) (Mar-11) :-2.88
Avg Rec (current)*:2.2
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Clinical Data, Inc. operates as a global biotechnology company developing early and late stage targeted therapeutics, as well as genetic and pharmacogenomic tests that detect serious diseases and help predict drug safety, tolerability, and efficacy.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices